过去一年中添加的文章,按日期排序

[HTML][HTML] A Comparison of the Epidemiological Characteristics Between Influenza and COVID-19 Patients: A Retrospective, Observational Cohort Study

O Naji, I Darwish, K Bessame, T Vaghela, A Hawkins… - Cureus, 2023 - ncbi.nlm.nih.gov
238 天前 - … evidence of viral pneumonitis significantly increase the odds of having COVID-19
compared to … Based on our findings, older age and radiographic evidence of viral pneumonitis

The role of infliximab in treating refractory cardiac sarcoidosis

R Ahmed, J Okafor, A Azzu, R Shi… - European Heart …, 2023 - academic.oup.com
244 天前 - … There were three new cases of infection (1 pneumonia and 2 COVID-19 pneumonitis)
and one case of renal cell carcinoma diagnosis three years after Infliximab treatment …

[PDF][PDF] RECOVERY-RS

GD Perkins, C Ji, BA Connolly… - This book has been … - mail.criticalcarereviews.com
244 天前 - … The clinical spectrum of COVID-19 ranges from … Severe COVID-19 pneumonitis
often results in hypoxaemic respiratory … support for patients with COVID-19 was a subject of …

Intracellular delivery of nuclear localization sequence peptide mitigates COVID-19 by inhibiting nuclear transport of inflammation-associated transcription factors

S Lee, SS Yoon, M Jo, M Kang, S Lee, YJ Seo, S Park… - Molecular Therapy, 2024 - cell.com
249 天前 - … agent for COVID-19 and various inflammatory diseases, we optimized its
therapeutic anti-inflammatory efficacy in various animal models in which pneumonitis had been …

Inhibition of bradykinin in SARS-CoV-2 infection: a randomised, double-blind trial of icatibant compared with placebo (ICASARS)

M Bailey, D Linden, O Earley, HG Parke, DF McAuley… - BMJ open, 2023 - bmjopen.bmj.com
252 天前 - … , and subsequently by a lymphocytic pneumonitis. Coagulopathy, thrombosis and
… icatibant use in COVID-19. In this study, hypoxic patients with COVID-19 within 7 days …

568P First-line (1L) osimertinib+ platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results

D Planchard, A Poltoratskiy, SW Kim… - Annals of …, 2023 - annalsofoncology.org
252 天前 - … No new cases of ILD/pneumonitis reported. New Grade ≥3 AEs included COVID-19/pneumonia
(n=1 each). New AEs leading to discontinuation: 4 pem (n=10 [33%] total); …

566P Safety of tepotinib+ osimertinib in EGFR-mutant NSCLC with MET amplification after first-line osimertinib

CK Liam, TM Kim, JJ Yang, C Huang… - Annals of …, 2023 - annalsofoncology.org
252 天前 - … TRAEs led to permanent discontinuation in six patients (7.9%), with pneumonitis
being the … ), one patient had pneumonitis, and one patient had respiratory failure (COVID-19). …

P180 Local early experience of Interstitial lung abnormalities in a targeted lung health check program

C Masey, A Iyer, K Leslie, R Riordan, C Daneshvar - 2023 - thorax.bmj.com
252 天前 - … ), 2 nonspecific interstitial pneumonia (NSIP), 3 postinflammatory/COVID-19
pneumonitis, 1 sarcoidosis, and 1 had hypersensitivity pneumonitis. In 17(52%) patients, ILAs were …

P155 Assessing continued benefits of 4C scores for mortality among patients with COVID-19 pneumonitis admitted to a teaching district general hospital

D Cox, K Koshy, N Moudgil, A Makan, E Crawford… - 2023 - thorax.bmj.com
252 天前 - … introduced early during the COVID-19 pandemic. With the … virulence of the
coronavirus (now predominantly omicron)… infection and COVID-19 pneumonitis admitted during 2 …

OA06. 04 Surgery after Neoadjuvant Immuno-Chemoradiotherapy in (Borderline) Resectable NSCLC: Results from the INCREASE Trial

C Dickhoff, D Heineman, F Schneiders, I Houda… - Journal of Thoracic …, 2023 - Elsevier
253 天前 - … Four patients did not proceed to surgery: 1 died due to COVID-19 during treatment,
2 had disease progression and 1 patient for whom resection of 3 vertebrae would have …